<DOC>
	<DOCNO>NCT02878122</DOCNO>
	<brief_summary>Epithelial ovarian cancer ( EOC ) poor prognosis . EOC management require debulking surgery chemotherapy base taxol carboplatine . Initial response often good , often recurrence occur first 18 month . Early recurrence sign chemoresistance palliative treatment . The study predictive clinical biological factor require adapt therapeutic develop new treatment .</brief_summary>
	<brief_title>Study Predictive Factors Chemoresistance Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>patient &gt; 18 year age patient histological proven epithelial ovarian cancer patient give consent patient without ovarian cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>ovarian cancer</keyword>
	<keyword>chemo resistance</keyword>
	<keyword>predictive factor</keyword>
	<keyword>cohort study</keyword>
	<keyword>bio bank</keyword>
</DOC>